Oxford University Innovation is the commercialisation arm of the University of Oxford, translating academic research into real-world applications and spin-out businesses.
Portfolio
3
companies
Brainomix
Artificial intelligence software for medical imaging diagnostics.
MoA Technology
MoA Technology develops next-generation herbicides to combat global weed resistance.
Zegami
Zegami provides visual data exploration software that helps businesses unlock insights from complex datasets.
Adam Workman
Head of Oxford University Innovation Investments and New Ventures
Adam leads investments and new ventures at Oxford University Innovation. He brings extensive portfolio management experience from roles including trustee at Applied Microbiology International and non-executive director across several technology companies.
LinkedInThe Series C round was co-led by Oxford Science Enterprises and Supernova Invest to support product development.
"When we helped spin Moa out from the University of Oxford’s Plant Sciences Department in 2017, we saw that its technology platform had a unique and important approach to address the market’s need for herbicides capable of breaking weed resistance,"
The financing round was co-led by Boehringer Ingelheim Venture Fund and Parkwalk Advisors, with participation from Tencent and Oxford University Innovation Fund.
"Over the past decade Brainomix has created the market for stroke AI imaging. As a spin-out from the University of Oxford it is an example of the UK's world-leading strengths in life sciences and AI-enabled medtech, combining expertise in clinical care and software development with more than 150 years' experience in the field across its leadership team."
The financing round was led by RT Capital Management alongside the Oxford Technology and Innovations EIS Fund.
"Over the last few years Zegami has been developing a cutting edge Visual Data Exploration platform to democratise data analytics, enabling people to make sense of the tsunami of data available today."
